Results 181 to 190 of about 3,536 (218)
The Differential Diagnosis and Treatment of Thrombotic Microangiopathies. [PDF]
Dtsch Arztebl Int, 2018 Bommer M +3 more
europepmc +1 more source
Polish journal of pathology : official journal of the Polish Society of Pathologists, 2012 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2002
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Joel L Moake, Moake Joel L
exaly +7 more sources
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation.
Joel L Moake, Moake Joel L
exaly +7 more sources
Seminars in Arthritis and Rheumatism, 2014 To review the clinical features and pathophysiologic mechanisms of the thrombotic microangiopathies (TMAs) including acquired and congenital thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced and atypical (non-Shiga toxin-induced) hemolytic uremic syndrome (HUS), and the TMAs associated with pregnancy, drugs, and organ transplantation ...
Sheerin NS, Neil S. Sheerin
openaire +3 more sources
Emergency Medicine Clinics of North AmericaThrombotic microangiopathies (TMAs) are rare diseases characterized by endothelial injury and microvascular clots. TMAs often lead to microangiopathic hemolytic anemia, thrombocytopenia, and end organ damage. Common TMA types include thrombotic thrombocytopenic purpura (TTP), infection-associated hemolytic uremic syndrome, and complement-mediated TMAs.
Ramy, Hanna +2 more
openaire +3 more sources
Thrombotic microangiopathies during pregnancy: The obstetrical and neonatal perspective [PDF]
European Journal of Obstetrics, Gynecology and Reproductive Biology, 2019 Thrombotic Microangiopathies during pregnancy and puerperium are very rare and, if undiagnosed, can be lifethreating. Pregnancy and postpartum can represent a trigger in predisposed patients.
Laura Sarno +2 more
exaly +3 more sources
Blood, 2012 Thrombotic microangiopathies (TMAs) are a group of life-threatening disorders characterized by thrombocytopenia, fragmentation of erythrocytes, and ischemic organ damage. Genetic disorders, autoimmune disease, and cancer are risk factors for TMAs, but an
Tobias A Fuchs +2 more
exaly +2 more sources
[Thrombotic microangiopathies].
Ugeskrift for laeger, 2009 The thrombotic microangiopathic diseases, which include acquired and congenital TTP and HUS, are most frequently acute disease entities. Untreated, these diseases are associated with a lethal course in many cases. Deficiency of the von Willebrand cleaving enzyme, ADAMTS13, is a decisive pathophysiological defect in most cases of thrombotic ...
Nielsen, O.J., Friis-Hansen, L.
openaire +2 more sources
Transfusion and Apheresis Science, 2011
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA.
M, Mörtzell +18 more
openaire +2 more sources
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA.
M, Mörtzell +18 more
openaire +2 more sources
European Journal of Internal Medicine, 2000
The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while ...
, Pisoni, , Remuzzi
openaire +2 more sources
The term 'thrombotic microangiopathy' (TMA) describes syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation. The term 'hemolytic uremic syndrome' (HUS) has entered clinical use to describe childhood cases of TMA dominated by renal impairment, while ...
, Pisoni, , Remuzzi
openaire +2 more sources